Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001641172-25-017072

Options or other derivatives

  • Director acquired 40,565 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
TANNENBAUM RENEE P Director 2025-06-26 Grant or award · Stock Options +40,565 168,766 D
Loading xslF345X05/ownership.xml…